Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Untargeted blood serum proteomics identifies novel proteins related to neurological recovery after human spinal cord injury

Untargeted blood serum proteomics identifies novel proteins related to neurological recovery after human spinal cord injury

Journal of Translational Medicine, 2024 · DOI: https://doi.org/10.1186/s12967-024-05344-y · Published: May 24, 2024

Spinal Cord InjuryBioinformatics

Simple Explanation

This study looked for proteins in the blood that could predict recovery after spinal cord injury (SCI). Researchers compared blood samples from patients who showed strong recovery to those who did not recover between 30 and 120 days after the injury. The scientists used a method to remove the most common proteins in the blood, allowing them to find less common proteins that might be important for recovery. They then used statistical models to identify proteins linked to neurological recovery and validated some of these proteins using ELISA. The study found that differences in recovery after SCI are linked to changes in proteins related to inflammation, blood clotting, and fat metabolism. Specifically, high levels of SERPINE1 and ARHGAP35 were associated with strong recovery, while high levels of CD300a and DEFA1 were associated with a lack of recovery.

Study Duration
30 to 120 days post-injury
Participants
30 patients with motor complete traumatic spinal cord injury (SCI)
Evidence Level
Not specified

Key Findings

  • 1
    Differences in subacute recovery after SCI (from 30 to 120 days) are associated with an enrichment in proteins involved in inflammation, coagulation, and lipid metabolism.
  • 2
    High levels of SERPINE1 and ARHGAP35 are associated with strong neurological recovery.
  • 3
    High levels of CD300a and DEFA1 are associated with a lack of recovery.

Research Summary

This study used untargeted proteomics to identify new candidate biomarkers in blood serum related to neurological recovery after spinal cord injury (SCI). The study found that proteins involved in inflammation, coagulation, and lipid metabolism are associated with differences in subacute recovery after SCI. The study validates that high levels of SERPINE1 and ARHGAP35 are associated with strong neurological recovery, while high levels of CD300a and DEFA1 are associated with a lack of recovery.

Practical Implications

Biomarker Identification

SERPINE1, ARHGAP35, CD300a, and DEFA1 may serve as potential biomarkers for predicting neurological recovery after SCI.

Therapeutic Targets

The identified proteins may represent novel therapeutic targets for interventions aimed at improving neurological recovery after SCI.

Personalized Medicine

These findings could contribute to the development of personalized treatment strategies based on individual biomarker profiles.

Study Limitations

  • 1
    The limited amount of sera restricted the validation of all proteins with an FDR < 0.1.
  • 2
    The lack of sensitivity of available ELISA tests limited the validation of some selected proteins.
  • 3
    Future studies should be conducted to test whether our results are generalizable in an independent validation cohort.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury